About Us

Mindstrong is a healthcare innovation company transforming brain health through pioneering work in measurement science and new models of care delivery. Mindstrong’s health platform seeks to connect patients and providers with continuous, objective measures of cognition and mood giving patients agency in their care and providers confidence that they will be alerted to early signs of mental health deterioration.

Our Values : Science That Makes a Difference.
  • We value curiosity, high quality data, rigorous analysis, innovation. We believe that scientific excellence is the foundation for improved medicine.
  • Our goals are defined by the needs of patients and individuals – we build products for objective measurement but we also attend to subjective experience.
Measuring Success
  • Our goals are to detect deterioration early and intervene in timely ways to reduce disability, hospitalization, and ER visits.

  • We shift healthcare from reactive to proactive.


Mindstrong was founded by three of the world’s leading authorities in neuroscience, medicine, and artificial intelligence. Mindstrong is based on their shared vision to redefine neuropsychiatric healthcare, transforming diagnosis and delivering precision therapy.

Leadership Team

Mindstrong’s executive team is comprised of passionate leaders with unrivaled experience in data science, neuroscience, software engineering, health information systems, and business.

Board of Directors

Mindstrong's Board of Directors bring deep experience working at the intersection of academia and industry.

Rick Klausner, MD

Co-Founder and Executive Chairman, Mindstrong Health

Sarah London

Senior Principal, Optum Ventures

Tom Insel, MD

Co-Founder and President, Mindstrong Health

CEO and Founder, Foresite Capital

Robert Epstein, MD

CEO, Epstein Health

Paul Dagum, MD PHD

Founder and Chief Executive Officer, Mindstrong Health

Scientific Advisory Board

Mindstrong's Scientific Advisory Board provides leading scientific oversight and guidance.

Sir Philip Campbell, PhD

Editor-in-Chief, Nature,
part of Nature Publishing Group

Ian Gotlib, PhD

Professor and Chair, Psychology,
Stanford University

Sophia Vinogradov, MD

Professor and Head, Department of Psychiatry,
University of Minnesota

Amit Etkin, MD, PhD

Associate Professor of Psychiatry andBehavioral Science,
Stanford University

Michael Frumkin, MS

Director, Google Accelerated Science;

Ethical-Legal-Social Implications (ELSI) Board

Mindstrong's ELSI Board ensures that digital biomarkers for the diagnosis and treatment of mental health conditions earns and maintains public trust.

Paul Gionfriddo

President & CEO, Mental Health America

Brandon Staglin

Director, One Mind

Nev Jones, PhD

Director of Research, Felton Institute

Nicole Martinez, PhD, JD

Postdoctoral Fellow, Stanford Bioethics

Sharon Terry, MA

President & CEO, Genetic Alliance

Katherine Switz, MBA

Founder & Executive Director, The Stability Network

Monica Luke

Executive Director, Living Assistance Fund


Mindstrong’s investors have launched some of the most transformative biotechnology and healthcare companies in neuropsychiatry and neurodegeneration.

Intellectual Property

Mindstrong has developed and patented a biomarker panel that measures brain function from interaction patterns captured passively and continuously from human-computer interfaces found in ubiquitous mobile technology.


Join our Team

Mindstrong Health is building a team of the strongest minds in the business. If youre looking for an exciting career, join the team.